Lilly Diabetes presents Phase II blood pressure and heart rate data
22 May 2012 | By Eli Lilly and Company
Phase II trial used ambulatory blood pressure monitoring to evaluate blood pressure and heart rate for dulaglutide...
List view / Grid view
News
Boehringer Ingelheim’s once-daily bronchodilator olodaterol* successfully completes Phase II clinical trial program in COPD
21 May 2012 | By Boehringer Ingelheim
Olodaterol significantly improved lung function (FEV 1) for at least 24 hours compared to placebo...
Fast plasma sample cleanup with new Phree Phospholipid Removal Plates
21 May 2012 | By Phenomenex Inc
Phenomenex Inc., introduces Phree Phospholipid Removal Plates for fast cleanup of plasma samples...
FDA approves new labeling for ISENTRESS® (raltegravir)
21 May 2012 | By Merck
The U.S. FDA approved a labeling update for ISENTRESS® Film-coated Tablets to include 156-week data from the STARTMRK study...
Capital increase in Lundbeck as a result of employee warrant programme
21 May 2012 | By H. Lundbeck A/S
Lundbeck increases its share capital by 593 shares as a result of employee warrant exercise...
Two overall winners announced at prestigious national award ceremony in London’s Science Museum
18 May 2012 | By GlaxoSmithKline
Judges of the GSK IMPACT Awards could not choose one overall winner for the awards...
New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine
18 May 2012 | By Biogen Idec / Elan Corporation plc
Use of biomarker has potential to advance personalised treatment for MS patients...
NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN)
18 May 2012 | By Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals announce results of an investigational Phase 3 study...
Pfizer exploratory study measures effects of Lyrica (pregabalin) on brain activity in fibromyalgia patients
18 May 2012 | By Pfizer
Results of studies on Lyrica® announced...
GSK statement on tender offer to acquire Human Genome Sciences
18 May 2012 | By GlaxoSmithKline
GSK believes its offer represents full and fair value and is in the best interests of both companies’ shareholders...
ArQule and Daiichi Sankyo announce completion of patient recruitment in Phase 3 clinical trial of Tivantinib in non-small cell lung cancer
18 May 2012 | By Daiichi Sankyo
ArQule and Daiichi Sankyo announced that recruitment of patients has been completed...
Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients
17 May 2012 | By Novartis
Results from pivotal Phase III GLOW2 study...
Teva’s Board of Directors votes to re-elect Dr. Phillip Frost as Chairman of the Board
17 May 2012 | By Teva Pharmaceutical Industries Ltd
“Dr. Phillip Frost has the Board’s full support..."
Amgen’s BiTE® Antibody Blinatumomab achieved high rate of complete response in adult patients with relapsed or refractory acute lymphoblastic leukemia
16 May 2012 | By Amgen
Updated results from a Phase 2 study...
GlaxoSmithKline completes transaction to increase its ownership in Theravance
16 May 2012 | By GlaxoSmithKline
GSK and Theravance, Inc. announced that following approval by Theravance...
